Bathi resik saben saham (EPS TTM): Nephros Corp (NEPH)

Nephros, Inc. demonstrates high macro resilience driven by recurring cartridge sales and mandatory infection control. Revenues are based on government medical standards and demand for dialysis systems. On GURU.Markets, the trailing 12-month earnings per share trend helps assess business quality, where 0.17 reflects the metric's baseline. Growth prospects are supported by the implementation of eco-friendly ultrafiltration technologies and clean-build standards.

For Nephros, Inc. (NEPH), the production efficiency of ultrafiltration systems in the US is directly reflected in the equity income. This metric is calculated by dividing the total net income for the rolling year by the total number of shares. By analyzing the annual net income per share, an investor can see the real return on the automation of assembly lines. This chart's price action reveals hidden margin compression. A stable trend confirms the financial resilience of the mechanical engineering cycle.